Publications and related articles about us and the wound care industry

20th SAfW Symposium – Advantages of COMS® technology

24 Nov 2021

Dr. Jürg Traber and Maria Signer from Venenklinik Bellevue shared their experience about the advantages of COMS® Therapy at the 20th SAfW Symposium.

Read more
20th SAfW Symposium – Advantages of COMS® technology
9th Balgrist Symposium on Diabetic Foot

24 Nov 2021

Dr. Martin Berli featured COMS® technology during his talk about new advanced treatment methods of diabetic foot ulcers.

Read more
9th Balgrist Symposium on Diabetic Foot
Piomic signs Cooperation Agreement with the Geblog AG

24 Nov 2021

We are proud to announce that we have signed a cooperation agreement with the Geblog AG.

Read more
Piomic signs Cooperation Agreement with the Geblog AG
Piomic Medical AG has been awarded with the Innosuisse Label.

24 Nov 2021

Piomic Medical AG has been awarded with the prestigious Innosuisse Label.

Read more
Piomic Medical AG has been awarded with the Innosuisse Label.
Piomic erhält das Exzellenzsiegel der Europäischen Kommission

24 Nov 2021

Piomic erhält das Exzellenzsiegel der Europäischen Kommission

Read more
Piomic erhält das Exzellenzsiegel der Europäischen Kommission
The COMS® One Therapy System Receives CE Mark

15 May 2020

Piomic Medical, has received CE certification for its Class IIa medical device. The COMS One Therapy System is intended to promote wound healing in chronic leg and foot ulcers.

Read more
The COMS® One Therapy System Receives CE Mark
Piomic is supported by the SME instrument

13 Nov 2019

Piomic was chosen for the SME instrument and funded under grant agreement No. 886276 from the European Union’s Horizon 2020 research and innovation programme.

Read more
Piomic is supported by the SME instrument
Guest Speaker @EWMA 2019

06 Jun 2019

Chief scientific officer Marc Augsburger joining a #EWMAMasterclass to elaborate on the role of molecular oxygen in wound healing.

Read more
Guest Speaker @EWMA 2019

Events calendar

Don't miss our updates!
You must complete your email.
You must accept our Privacy Policy